Works matching DE "MEDICATION safety"

Results: 5000
    1
    2
    3
    4
    5
    6
    7

    The REMS Publication Paradox.

    Published in:
    Oncology (08909091), 2009, v. 23, n. 8, p. 715
    By:
    • Andrews, Elizabeth B.;
    • Kaye, James A.;
    • Van Bennekom, Carla
    Publication type:
    Article
    8
    9
    10

    Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study

    Published in:
    Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 184, doi. 10.1111/j.1476-5829.2011.00265.x
    By:
    • Chon, E.;
    • McCartan, L.;
    • Kubicek, L. N.;
    • Vail, D. M.
    Publication type:
    Article
    11
    12
    13
    14
    15

    Testing Times for the FDA.

    Published in:
    Bio-IT World, 2004, v. 3, n. 3, p. 40
    By:
    • Zimmerman, Zachary;
    • Flood, Sue;
    • Helton, Edward D.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Patient Partnership Tools to Support Medication Safety in Community-Dwelling Older Adults: Protocol for a Nonrandomized Stepped Wedge Clinical Trial.

    Published in:
    JMIR Research Protocols, 2024, v. 13, p. 1, doi. 10.2196/57878
    By:
    • Xiao, Yan;
    • Fulda, Kimberley G;
    • Young, Richard A;
    • Hendrix, Z Noah;
    • Daniel, Kathryn M;
    • Chen, Kay Yut;
    • Zhou, Yuan;
    • Roye, Jennifer L;
    • Kosmari, Ludmila;
    • Wilson, Joshua;
    • Espinoza, Anna M;
    • Sutcliffe, Kathleen M;
    • Pitts, Samantha I;
    • Arbaje, Alicia I;
    • Chui, Michelle A;
    • Blair, Somer;
    • Sloan, Dawn;
    • Jackson, Masheika;
    • Gurses, Ayse P
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
    By:
    • Piha-Paul, Sarina A;
    • Hann, Christine L;
    • French, Christopher A;
    • Cousin, Sophie;
    • Braña, Irene;
    • Cassier, Phillippe A;
    • Moreno, Victor;
    • Bono, Johann S de;
    • Harward, Sara Duckworth;
    • Ferron-Brady, Geraldine;
    • Barbash, Olena;
    • Wyce, Anastasia;
    • Wu, Yuehui;
    • Horner, Thierry;
    • Annan, Meg;
    • Parr, Nigel J;
    • Prinjha, Rabinder K;
    • Carpenter, Christopher L;
    • Hilton, John;
    • Hong, David S
    Publication type:
    Article